Thrombosis in myeloproliferative neoplasms: Treatment outcomes of direct oral anticoagulants and vitamin K antagonists

BACKGROUND: Patients with myeloproliferative neoplasms (MPNs), such as polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF), are at an increased risk of recurrent thromboembolic events (TEs) and hemorrhagic complications. Anticoagulation with vitamin K antagonists...

Descripción completa

Detalles Bibliográficos
Autores principales: Fedorov, Kateryna, Goel, Swati, Kushnir, Margarita, Billett, Henny H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440942/
https://www.ncbi.nlm.nih.gov/pubmed/34532628
http://dx.doi.org/10.1002/rth2.12574

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440942/
https://www.ncbi.nlm.nih.gov/pubmed/34532628
http://dx.doi.org/10.1002/rth2.12574

Ejemplares similares